The FDA has pledged to “move with all expediency” to review the company’s data on a lower-dose kids’ vaccine.
Us – CBSNews.com
The FDA has pledged to “move with all expediency” to review the company’s data on a lower-dose kids’ vaccine.
Us – CBSNews.com